Literature DB >> 22281942

Estimating net survival: the importance of allowing for informative censoring.

Coraline Danieli1, Laurent Remontet, Nadine Bossard, Laurent Roche, Aurélien Belot.   

Abstract

Net survival, the one that would be observed if cancer were the only cause of death, is the most appropriate indicator to compare cancer mortality between areas or countries. Several parametric and non-parametric methods have been developed to estimate net survival, particularly when the cause of death is unknown. These methods are based either on the relative survival ratio or on the additive excess hazard model, the latter using the general population mortality hazard to estimate the excess mortality hazard (the hazard related to net survival). The present work used simulations to compare estimator abilities to estimate net survival in different settings such as the presence/absence of an age effect on the excess mortality hazard or on the potential time of follow-up, knowing that this covariate has an effect on the general population mortality hazard too. It showed that when age affected the excess mortality hazard, most estimators, including specific survival, were biased. Only two estimators were appropriate to estimate net survival. The first is based on a multivariable excess hazard model that includes age as covariate. The second is non-parametric and is based on the inverse probability weighting. These estimators take differently into account the informative censoring induced by the expected mortality process. The former offers great flexibility whereas the latter requires neither the assumption of a specific distribution nor a model-building strategy. Because of its simplicity and availability in commonly used software, the nonparametric estimator should be considered by cancer registries for population-based studies.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22281942     DOI: 10.1002/sim.4464

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  25 in total

1.  Baseline mortality-adjusted survival in colon cancer patients.

Authors:  Kristjan Ukegjini; Marcel Zadnikar; Rene Warschkow; Sascha Müller; Bruno M Schmied; Lukas Marti
Journal:  Langenbecks Arch Surg       Date:  2016-04-21       Impact factor: 3.445

2.  Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).

Authors:  Claudia Allemani; Hannah K Weir; Helena Carreira; Rhea Harewood; Devon Spika; Xiao-Si Wang; Finian Bannon; Jane V Ahn; Christopher J Johnson; Audrey Bonaventure; Rafael Marcos-Gragera; Charles Stiller; Gulnar Azevedo e Silva; Wan-Qing Chen; Olufemi J Ogunbiyi; Bernard Rachet; Matthew J Soeberg; Hui You; Tomohiro Matsuda; Magdalena Bielska-Lasota; Hans Storm; Thomas C Tucker; Michel P Coleman
Journal:  Lancet       Date:  2014-11-26       Impact factor: 79.321

3.  Estimation of net survival for cancer patients: Relative survival setting more robust to some assumption violations than cause-specific setting, a sensitivity analysis on empirical data.

Authors:  Robin Schaffar; Bernard Rachet; Aurélien Belot; Laura M Woods
Journal:  Eur J Cancer       Date:  2016-12-24       Impact factor: 9.162

4.  Baseline mortality-adjusted survival in resected rectal cancer patients.

Authors:  Ignazio Tarantino; Sascha A Müller; Rene Warschkow; Yakup Kulu; Bruno M Schmied; Markus W Büchler; Alexis Ulrich
Journal:  J Gastrointest Surg       Date:  2014-08-05       Impact factor: 3.452

5.  Long-Term Survival is not Impaired After the Complete Resection of Neuroendocrine Tumors of the Appendix.

Authors:  Thomas Steffen; Sabrina M Ebinger; René Warschkow; Cornelia Lüthi; Bruno M Schmied; Thomas Clerici
Journal:  World J Surg       Date:  2015-11       Impact factor: 3.352

6.  Breast cancer survival in the US and Europe: a CONCORD high-resolution study.

Authors:  Claudia Allemani; Milena Sant; Hannah K Weir; Lisa C Richardson; Paolo Baili; Hans Storm; Sabine Siesling; Ana Torrella-Ramos; Adri C Voogd; Tiiu Aareleid; Eva Ardanaz; Franco Berrino; Magdalena Bielska-Lasota; Susan Bolick; Claudia Cirilli; Marc Colonna; Paolo Contiero; Rosemary Cress; Emanuele Crocetti; John P Fulton; Pascale Grosclaude; Timo Hakulinen; M Isabel Izarzugaza; Per Malmström; Karin Peignaux; Maja Primic-Žakelj; Jadwiga Rachtan; Chakameh Safaei Diba; Maria-José Sánchez; Maria J Schymura; Tiefu Shen; Adele Traina; Laufey Tryggvadottir; Rosario Tumino; Michel Velten; Marina Vercelli; Holly J Wolf; Anne-Sophie Woronoff; Xiaocheng Wu; Michel P Coleman
Journal:  Int J Cancer       Date:  2012-09-18       Impact factor: 7.396

7.  Performance of two formal tests based on martingales residuals to check the proportional hazard assumption and the functional form of the prognostic factors in flexible parametric excess hazard models.

Authors:  Coraline Danieli; Nadine Bossard; Laurent Roche; Aurelien Belot; Zoe Uhry; Hadrien Charvat; Laurent Remontet
Journal:  Biostatistics       Date:  2017-07-01       Impact factor: 5.899

8.  Prostate cancer: net survival and cause-specific survival rates after multiple imputation.

Authors:  Adeline Morisot; Faïza Bessaoud; Paul Landais; Xavier Rébillard; Brigitte Trétarre; Jean-Pierre Daurès
Journal:  BMC Med Res Methodol       Date:  2015-07-28       Impact factor: 4.615

9.  Direct modeling of the crude probability of cancer death and the number of life years lost due to cancer without the need of cause of death: a pseudo-observation approach in the relative survival setting.

Authors:  Dimitra-Kleio Kipourou; Maja Pohar Perme; Bernard Rachet; Aurelien Belot
Journal:  Biostatistics       Date:  2022-01-13       Impact factor: 5.899

10.  Conditional survival of cancer patients: an Australian perspective.

Authors:  Xue Qin Yu; Peter D Baade; Dianne L O'Connell
Journal:  BMC Cancer       Date:  2012-10-08       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.